A selection of medical devices for joint clinical assessment should be made based on specific criteria.
A selection of medical devices for joint clinical assessment should be made based on specific criteria .
Such scanning should facilitate the prioritisation of technologies that are to be selected for joint clinical assessment.
The fundamental aim of the proposal is to introduce a joint clinical assessment of health technologies at EU level.
Such scanning should facilitate the prioritisation of technologies that are to be selected by the Coordination Group for joint clinical assessment.
(b) the initial joint clinical assessment report specified the need for an update once additional evidence for further assessment is available.
The Coordination Group shall select the medical devices referred to in paragraph 1 points (b), (ba) and (c) for joint clinical assessment based on the following criteria:
The Coordination Group shall select the medical devices referred to in paragraph 1 points (b) and (c) for joint clinical assessment based onif the device in question fulfils all of the following criteria:
For the health technologies included on the List of Assessed Health Technologies or in respect of which a joint clinical assessment has been initiated, Member States shall:
For the health technologies included on the List of Assessed Health Technologies or in respect of which a joint clinical assessment has been initiated , Member States shall:
Member States shall notify the Commission of the outcome of a health technology assessment on a health technology which has been subject to a joint clinical assessment within 30 days from its completion.
Member States shallmay notify the Commission of the outcome of a health technology assessment on a health technology which has been subject to a joint clinical assessment within 30 days from its completion.
The Coordination Group shall select the medical devices referred to in paragraph 1 points (b), (ba) and (c) for joint clinical assessment based on the following criteria:
(ii) select medicinal products referred to in Article 5(1)(a) for joint clinical assessment based on the following selection criteria referred to in Article 5(2).:
The funding should cover the costs of producing joint clinical assessment and joint scientific consultation reports.
The funding should cover the costs of producing joint clinical assessment and joint scientific consultation reports .
Member States shallmay notify the Commission of the outcome of a health technology assessment on a health technology which has been subject to a joint clinical assessment within 30 days from its completion.
Member States shall notify the Commission of the outcome of a health technology assessment on a health technology which has been subject to a joint clinical assessment within 30 days from its completion.
Member States shall notify the Commission of the outcome of a health technology assessment on a health technology which has been subject to a joint clinical assessment within 30 days from itsthe completion of the national/regional report.
The conclusions of the joint clinical assessment report shall be limited to the following:
The conclusions of the joint clinical assessment report shall be limited to the following :
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод